申请人:Pfizer Inc.
公开号:US04002623A1
公开(公告)日:1977-01-11
1-[3-(Dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)propyl]imidazo[4,5-b]pyridines and salts thereof with pharmaceutically acceptable acids, a novel class of compounds useful in the treatment of inflammatory conditions. Alternate methods of preparation are provided and the primary synthetic route is described in detail.
1-[3-(二烷基氨基)丙基]-2-酰胺基苯并咪唑和2-酰胺基氨基-3-[3-(二烷基氨基)丙基]咪唑并[4,5-b]吡啶以及它们与药用可接受的酸盐,是一类新型化合物,在治疗炎症性疾病中有用。提供了替代制备方法,并详细描述了主要的合成途径。